| Year |
Citation |
Score |
| 2002 |
Naranda T, Kaufman RI, Li J, Wong K, Boge A, Hallén D, Fung KY, Duncan MW, Andersen N, Goldstein A, Olsson L. Activation of erythropoietin receptor through a novel extracellular binding site. Endocrinology. 143: 2293-302. PMID 12021194 DOI: 10.1210/Endo.143.6.8860 |
0.308 |
|
| 1997 |
Naranda T, Goldstein A, Olsson L. A peptide derived from an extracellular domain selectively inhibits receptor internalization: Target sequences on insulin and insulin-like growth factor 1 receptors Proceedings of the National Academy of Sciences of the United States of America. 94: 11692-11697. PMID 9326672 DOI: 10.1073/pnas.94.21.11692 |
0.354 |
|
| 1994 |
Xie GX, Meng F, Mansour A, Thompson RC, Hoversten MT, Goldstein A, Watson SJ, Akil H. Primary structure and functional expression of a guinea pig kappa opioid (dynorphin) receptor. Proceedings of the National Academy of Sciences of the United States of America. 91: 3779-83. PMID 8170987 DOI: 10.1073/Pnas.91.9.3779 |
0.409 |
|
| 1994 |
Olsson L, Goldstein A, Stagsted J. Regulation of receptor internalization by the major histocompatibility complex class I molecule Proceedings of the National Academy of Sciences of the United States of America. 91: 9086-9090. PMID 8090774 DOI: 10.1073/pnas.91.19.9086 |
0.331 |
|
| 1993 |
Stagsted J, Mapelli C, Meyers C, Matthews BW, Anfinsen CB, Goldstein A, Olsson L. Amino acid residues essential for biological activity of a peptide derived from a major histocompatibility complex class I antigen. Proceedings of the National Academy of Sciences of the United States of America. 90: 7686-90. PMID 8356070 DOI: 10.1073/Pnas.90.16.7686 |
0.322 |
|
| 1993 |
Meng F, Xie GX, Thompson RC, Mansour A, Goldstein A, Watson SJ, Akil H. Cloning and pharmacological characterization of a rat kappa opioid receptor. Proceedings of the National Academy of Sciences of the United States of America. 90: 9954-8. PMID 8234341 DOI: 10.1073/Pnas.90.21.9954 |
0.303 |
|
| 1992 |
Xie GX, Miyajima A, Goldstein A. Expression cloning of cDNA encoding a seven-helix receptor from human placenta with affinity for opioid ligands Proceedings of the National Academy of Sciences of the United States of America. 89: 4124-4128. PMID 1315051 DOI: 10.1073/Pnas.89.9.4124 |
0.418 |
|
| 1991 |
Goldstein A. Heroin addiction: Neurobiology, pharmacology, and policy† Journal of Psychoactive Drugs. 23: 123-133. PMID 1662715 DOI: 10.1080/02791072.1991.10472231 |
0.356 |
|
| 1990 |
Stagsted J, Reaven GM, Hansen T, Goldstein A, Olsson L. Regulation of insulin receptor functions by a peptide derived from a major histocompatibility complex class I antigen Cell. 62: 297-307. PMID 2196997 DOI: 10.1016/0092-8674(90)90367-N |
0.315 |
|
| 1990 |
Xie GX, Miyajima A, Yokota T, Arai KI, Goldstein A. Chimeric opioid peptides: Tools for identifying opioid receptor types Proceedings of the National Academy of Sciences of the United States of America. 87: 3180-3184. PMID 2158105 DOI: 10.1073/Pnas.87.8.3180 |
0.446 |
|
| 1990 |
Goldstein A, Naidu A. Dextrorphan binds to opioid receptors in guinea-pig brain membranes and is an antagonist at opioid receptors in myenteric plexus Proceedings of the National Academy of Sciences of the United States of America. 87: 1629-1632. PMID 2155421 DOI: 10.1073/Pnas.87.5.1629 |
0.439 |
|
| 1989 |
Hansen T, Stagsted J, Pedersen L, Roth RA, Goldstein A, Olsson L. Inhibition of insulin receptor phosphorylation by peptides derived from major histocompatibility complex class I antigens Proceedings of the National Academy of Sciences of the United States of America. 86: 3123-3126. PMID 2566166 DOI: 10.1073/Pnas.86.9.3123 |
0.301 |
|
| 1988 |
Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. 6-Acetylmorphine: a natural product present in mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 85: 5335-8. PMID 3393541 DOI: 10.1073/Pnas.85.14.5335 |
0.619 |
|
| 1988 |
Goldstein A, Nestor JJ, Naidu A, Newman SR. 'DAKLI': A multipurpose ligand with high affinity and selectivity for dynorphin (κ opioid) binding sites Proceedings of the National Academy of Sciences of the United States of America. 85: 7375-7379. PMID 2902630 DOI: 10.1073/Pnas.85.19.7375 |
0.418 |
|
| 1988 |
Sibinga NES, Goldstein A. Opioid peptides and opioid receptors in cells of the immune system Annual Review of Immunology. 6: 219-249. PMID 2838048 DOI: 10.1146/ANNUREV.IY.06.040188.001251 |
0.33 |
|
| 1987 |
Weitz CJ, Faull KF, Goldstein A. Synthesis of the skeleton of the morphine molecule by mammalian liver. Nature. 330: 674-7. PMID 3683586 DOI: 10.1038/330674A0 |
0.631 |
|
| 1986 |
Barrett RW, James IF, Goldstein A. Comparative immuno-removal: A novel method for estimating the concentration of an unknown immunoreactive compound Biochemical and Biophysical Research Communications. 137: 316-322. PMID 3521606 DOI: 10.1016/0006-291X(86)91212-X |
0.302 |
|
| 1986 |
Weitz CJ, Lowney LI, Faull KF, Feistner G, Goldstein A. Morphine and codeine from mammalian brain. Proceedings of the National Academy of Sciences of the United States of America. 83: 9784-8. PMID 3467337 DOI: 10.1073/Pnas.83.24.9784 |
0.607 |
|
| 1986 |
Devi L, Goldstein A. Opioid and other peptides as inhibitors of leumorphin (dynorphin B-29) converting activity Peptides. 7: 87-90. PMID 3012492 DOI: 10.1016/0196-9781(86)90066-5 |
0.358 |
|
| 1985 |
Goldstein A, Barrett RW, James IF, Lowney LI, Weitz CJ, Knipmeyer LL, Rapoport H. Morphine and other opiates from beef brain and adrenal. Proceedings of the National Academy of Sciences of the United States of America. 82: 5203-7. PMID 3860854 DOI: 10.1073/pnas.82.15.5203 |
0.641 |
|
| 1985 |
Civelli O, Douglass J, Goldstein A, Herbert E. Sequence and expression of the rat prodynorphin gene. Proceedings of the National Academy of Sciences of the United States of America. 82: 4291-5. PMID 3858883 DOI: 10.1073/Pnas.82.12.4291 |
0.311 |
|
| 1985 |
Barrett RW, Goldstein A. A monoclonal antibody specific for a dynorphin precursor Neuropeptides. 6: 113-120. PMID 2860615 DOI: 10.1016/0143-4179(85)90102-7 |
0.346 |
|
| 1984 |
Cox BM, Goldstein A, Nelson WT. Nicotine self-administration in rats. British Journal of Pharmacology. 83: 49-55. PMID 6487896 DOI: 10.1111/J.1476-5381.1984.Tb10118.X |
0.511 |
|
| 1984 |
Han JS, Xie GX, Goldstein A. Analgesia induced by intrathecal injection of dynorphin B in the rat Life Sciences. 34: 1573-1579. PMID 6371415 DOI: 10.1016/0024-3205(84)90612-X |
0.386 |
|
| 1984 |
Chavkin C, Goldstein A. Opioid receptor reserve in normal and morphine-tolerant guinea pig ileum myenteric plexus. Proceedings of the National Academy of Sciences of the United States of America. 81: 7253-7. PMID 6095280 DOI: 10.1073/Pnas.81.22.7253 |
0.611 |
|
| 1984 |
Goldstein A, James IF. Multiple opioid receptors criteria for identification and classification Trends in Pharmacological Sciences. 5: 503-505. DOI: 10.1016/0165-6147(84)90527-3 |
0.37 |
|
| 1983 |
Goldstein A. Some thoughts about endogenous opioids and addiction Drug and Alcohol Dependence. 11: 11-14. PMID 6303738 DOI: 10.1016/0376-8716(83)90088-1 |
0.332 |
|
| 1983 |
McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Dynorphin is contained within hippocampal mossy fibers: immunochemical alterations after kainic acid administration and colchicine-induced neurotoxicity. Proceedings of the National Academy of Sciences of the United States of America. 80: 589-93. PMID 6132379 DOI: 10.1073/pnas.80.2.589 |
0.467 |
|
| 1983 |
Watson SJ, Khachaturian H, Taylor L, Fischli W, Goldstein A, Akil H. Pro-dynorphin peptides are found in the same neurons throughout rat brain: immunocytochemical study. Proceedings of the National Academy of Sciences of the United States of America. 80: 891-4. PMID 6131416 DOI: 10.1073/Pnas.80.3.891 |
0.403 |
|
| 1982 |
Cone RI, Goldstein A. A specific radioimmunoassay for the opioid peptide dynorphin B in neural tissues Neuropeptides. 3: 97-106. PMID 7162565 DOI: 10.1016/0143-4179(82)90005-1 |
0.391 |
|
| 1982 |
McGinty JF, Henriksen SJ, Goldstein A, Terenius L, Bloom FE. Opioid peptide identity and localization in hippocampus. Life Sciences. 31: 1797-800. PMID 6759828 DOI: 10.1016/0024-3205(82)90213-2 |
0.474 |
|
| 1982 |
Chavkin C, Goldstein A. Reduction in opiate receptor reserve in morphine tolerant guinea pig ilea. Life Sciences. 31: 1687-90. PMID 6296572 DOI: 10.1016/0024-3205(82)90186-2 |
0.608 |
|
| 1982 |
Khachaturian H, Watson SJ, Lewis ME, Coy D, Goldstein A, Akil H. Dynorphin immunocytochemistry in the rat central nervous system. Peptides. 3: 941-54. PMID 6132365 DOI: 10.1016/0196-9781(82)90063-8 |
0.352 |
|
| 1982 |
James IF, Chavkin C, Goldstein A. Preparation of brain membranes containing a single type of opioid receptor highly selective for dynorphin. Proceedings of the National Academy of Sciences of the United States of America. 79: 7570-4. PMID 6130527 DOI: 10.1073/Pnas.79.23.7570 |
0.583 |
|
| 1982 |
Fischli W, Goldstein A, Hunkapiller MW, Hood LE. Two "big" dynorphins from porcine pituitary Life Sciences. 31: 1769-1772. PMID 6130436 DOI: 10.1016/0024-3205(82)90206-5 |
0.358 |
|
| 1982 |
Watson SJ, Khachaturian H, Akil H, Coy DH, Goldstein A. Comparison of the distribution of dynorphin systems and enkephalin systems in brain. Science (New York, N.Y.). 218: 1134-6. PMID 6128790 DOI: 10.1126/Science.6128790 |
0.402 |
|
| 1982 |
James IF, Chavkin C, Goldstein A. Selectivity of dynorphin for kappa opioid receptors. Life Sciences. 31: 1331-4. PMID 6128656 DOI: 10.1016/0024-3205(82)90374-5 |
0.617 |
|
| 1982 |
Cone RI, Goldstein A. A dynorphin-like opioid in the central nervous system of an amphibian Proceedings of the National Academy of Sciences of the United States of America. 79: 3345-3349. PMID 6124969 DOI: 10.1073/Pnas.79.10.3345 |
0.406 |
|
| 1982 |
Chavkin C, James IF, Goldstein A. Dynorphin is a specific endogenous ligand of the kappa opioid receptor. Science (New York, N.Y.). 215: 413-5. PMID 6120570 DOI: 10.1126/Science.6120570 |
0.624 |
|
| 1982 |
Chavkin C, James IF, Goldstein A. Dynorphin is a specific endogenous ligand of the κ opioid receptor Pain. 14: 201. DOI: 10.1016/0304-3959(82)90120-8 |
0.603 |
|
| 1982 |
Leslie FM, Goldstein A. Degradation of dynorphin-(1-13) by membrane-bound rat brain enzymes Neuropeptides. 2: 185-196. DOI: 10.1016/0143-4179(82)90051-8 |
0.37 |
|
| 1981 |
Chavkin C, Goldstein A. Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexus. Nature. 291: 591-3. PMID 6264311 DOI: 10.1038/291591a0 |
0.638 |
|
| 1981 |
Dent RR, Guilleminault C, Albert LH, Posner BI, Cox BM, Goldstein A. Diurnal rhythm of plasma immunoreactive beta-endorphin and its relationship to sleep stages and plasma rhythms of cortisol and prolactin. The Journal of Clinical Endocrinology and Metabolism. 52: 942-7. PMID 6262357 DOI: 10.1210/Jcem-52-5-942 |
0.503 |
|
| 1981 |
Botticelli LJ, Cox BM, Goldstein A. Immunoreactive dynorphin in mammalian spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 78: 7783-6. PMID 6121324 |
0.451 |
|
| 1981 |
Goldstein A, Fischli W, Lowney LI, Hunkapiller M, Hood L. Porcine pituitary dynorphin: complete amino acid sequence of the biologically active heptadecapeptide Proceedings of the National Academy of Sciences of the United States of America. 78: 7219-7223. PMID 6118870 DOI: 10.1073/Pnas.78.11.7219 |
0.379 |
|
| 1981 |
Chavkin C, Goldstein A. Specific receptor for the opioid peptide dynorphin: structure--activity relationships. Proceedings of the National Academy of Sciences of the United States of America. 78: 6543-7. PMID 6118865 DOI: 10.1073/Pnas.78.10.6543 |
0.626 |
|
| 1981 |
Herman BH, Goldstein A. Cataleptic effects of dynorphin-(1-13) in rats made tolerant to a mu opiate receptor agonist Neuropeptides. 2: 13-22. DOI: 10.1016/0143-4179(81)90047-0 |
0.352 |
|
| 1980 |
Judson BA, Himmelberger DU, Goldstein A. The naloxone test for opiate dependence Clinical Pharmacology & Therapeutics. 27: 492-501. PMID 7357808 DOI: 10.1038/Clpt.1980.69 |
0.322 |
|
| 1980 |
Herman BH, Leslie F, Goldstein A. Behavioral effects and in vivo degradation of intraventricularly administered dynorphin-(1-13) and D-Ala2-dynorphin-(1-11) in rats Life Sciences. 27: 883-892. PMID 7191035 DOI: 10.1016/0024-3205(80)90084-3 |
0.394 |
|
| 1980 |
Ghazarossian VE, Dent RR, Otsu K, Ross M, Cox B, Goldstein A. Development and validation of a sensitive radioimmunoassay for naturally occurring beta-endorphin-like peptides in human plasma. Analytical Biochemistry. 102: 80-9. PMID 6153517 DOI: 10.1016/0003-2697(80)90321-8 |
0.536 |
|
| 1980 |
Cox BM, Ghazarossian VE, Goldstein A. Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro rats. Neuroscience Letters. 20: 85-8. PMID 6133255 DOI: 10.1016/0304-3940(80)90238-4 |
0.604 |
|
| 1980 |
Goldstein A, Ghazarossian VE. Immunoreactive dynorphin in pituitary and brain. Proceedings of the National Academy of Sciences of the United States of America. 77: 6207-6210. PMID 6108564 DOI: 10.1073/Pnas.77.10.6207 |
0.394 |
|
| 1980 |
Ghazarossian VE, Chavkin C, Goldstein A. A specific radioimmunoassay for the novel opioid peptide dynorphin. Life Sciences. 27: 75-86. PMID 6105608 DOI: 10.1016/0024-3205(80)90021-1 |
0.608 |
|
| 1980 |
Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1–13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. DOI: 10.1016/0143-4179(80)90017-7 |
0.583 |
|
| 1980 |
Ho WKK, Cox BM, Chavkin C, Goldstein A. Opioid peptide dynorphin-(1-13): Adsorptive losses and potency estimates Neuropeptides. 1: 143-152. |
0.669 |
|
| 1979 |
Baizman ER, Cox BM, Osman OH, Goldstein A. Experimental alterations of endorphin levels in rat pituitary. Neuroendocrinology. 28: 402-14. PMID 572491 |
0.527 |
|
| 1979 |
Goldstein A, Tachibana S, Lowney LI, Hunkapiller M, Hood L. Dynorphin-(1-13), an extraordinarily potent opioid peptide Proceedings of the National Academy of Sciences of the United States of America. 76: 6666-6670. PMID 230519 DOI: 10.1073/Pnas.76.12.6666 |
0.457 |
|
| 1979 |
Lowney LI, Gentleman SB, Goldstein A. A pituitary endorphin with novel properties Life Sciences. 24: 2377-2384. PMID 225623 DOI: 10.1016/0024-3205(79)90536-8 |
0.448 |
|
| 1979 |
Cox BM, Ross M, Goldstein A, Palmour RM. Pharmacological and immunological characterization of the Leu5 analogue of human beta-endorphin. Brain Research. 165: 311-9. PMID 217494 DOI: 10.1016/0006-8993(79)90562-6 |
0.534 |
|
| 1978 |
Gentleman S, Lowney LI, Cox BM, Goldstein A. Rapid purification of beta-endorphin by high-performance liquid chromatography. Journal of Chromatography. 153: 274-8. PMID 659560 DOI: 10.1016/S0021-9673(00)89885-4 |
0.496 |
|
| 1978 |
Ross M, Ghazarossian V, Cox BM, Goldstein A. Radioimmunoassays for beta-endorphin: comparison of properties of two antisera. Life Sciences. 22: 1123-30. PMID 566365 DOI: 10.1016/0024-3205(78)90081-4 |
0.596 |
|
| 1978 |
Goldstein A, Naidu A. Opioid activity of a benzomorphan lacking an oxygen atom Biochemical Pharmacology. 27: 1033-1036. PMID 207286 DOI: 10.1016/0006-2952(78)90154-5 |
0.341 |
|
| 1978 |
Goldstein A, Grevert P. Placebo analgesia, endorphins, and naloxone. The Lancet. 312: 1385-1385. PMID 82889 DOI: 10.1016/S0140-6736(78)92026-3 |
0.364 |
|
| 1977 |
Goldstein A, Cox BM. Opioid peptides (endorphins) in pituitary and brain. Psychoneuroendocrinology. 2: 11-6. PMID 905473 DOI: 10.1016/0306-4530(77)90027-0 |
0.611 |
|
| 1977 |
Ross M, Dingledine R, Cox BM, Goldstein A. Distribution of endorphins (peptides with morphine-like pharmacological activity) in pituitary. Brain Research. 124: 523-32. PMID 851863 DOI: 10.1016/0006-8993(77)90951-9 |
0.681 |
|
| 1977 |
Cheung AL, Stavinoha WB, Goldstein A. Endorphins in brains of decapitated and microwave-killed mice Life Sciences. 20: 1285-1289. PMID 850478 DOI: 10.1016/0024-3205(77)90504-5 |
0.367 |
|
| 1977 |
Grevert P, Goldstein A. Effects of naloxone on experimentally induced ischemic pain and on mood in human subjects Proceedings of the National Academy of Sciences of the United States of America. 74: 1291-1294. PMID 322152 DOI: 10.1073/Pnas.74.3.1291 |
0.314 |
|
| 1977 |
Goldstein A, Cox BM, Klee WA, Nirenberg M. Endorphin from pituitary inhibits cyclic AMP formation in homogenates of neuroblastoma X glioma hybrid cells. Nature. 265: 362-3. PMID 189215 DOI: 10.1038/265362A0 |
0.558 |
|
| 1977 |
Goldstein A, Cox BM, Gentleman S, Lowney LI, Cheung AL. PITUITARY AND BRAIN OPIOID PEPTIDES (ENDORPHINS) Annals of the New York Academy of Sciences. 297: 108-114. DOI: 10.1111/J.1749-6632.1977.Tb41848.X |
0.634 |
|
| 1977 |
Goldstein A. Opioid peptides (endorphins) in pituitary and brain Pain. 3: 281. DOI: 10.1016/0304-3959(77)90009-4 |
0.445 |
|
| 1976 |
Goldstein A, Pryor GT, Otis LS, Larsen F. On the role of endogenous opioid peptides: Failure of naloxone to influence shock escape threshold in the rat Life Sciences. 18: 599-604. PMID 1263743 DOI: 10.1016/0024-3205(76)90339-8 |
0.315 |
|
| 1976 |
Cox BM, Goldstein A, Hi CH. Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin. Proceedings of the National Academy of Sciences of the United States of America. 73: 1821-3. PMID 1064855 |
0.566 |
|
| 1976 |
Goldstein A. Opioid peptides (endorphins) in pituitary and brain. Studies on opiate receptors have led to identification of endogenous peptides with morphine like actions Science. 193: 1081-1086. PMID 959823 DOI: 10.1126/Science.959823 |
0.422 |
|
| 1976 |
Cheung AL, Goldstein A. Failure of hypophysectomy to alter brain content of opioid peptides (endorphins) Life Sciences. 19: 1005-1008. PMID 186675 DOI: 10.1016/0024-3205(76)90291-5 |
0.401 |
|
| 1976 |
Cox BM, Gentleman S, Su TP, Goldstein A. Further characterization of morphine-like peptides (endorphins) from pituitary. Brain Research. 115: 285-96. PMID 10049 DOI: 10.1016/0006-8993(76)90513-8 |
0.629 |
|
| 1975 |
Goldstein A, Goldstein JS, Cox BM. A synthetic peptide with morphine-like pharmacologic action. Life Sciences. 17: 1643-54. PMID 1207378 DOI: 10.1016/0024-3205(75)90109-5 |
0.643 |
|
| 1975 |
Goldstein A, Lowery PJ. Effect of the opiate antagonist naloxone on body temperature in rats. Life Sciences. 17: 927-931. PMID 1195988 DOI: 10.1016/0024-3205(75)90445-2 |
0.396 |
|
| 1975 |
Teschemacher H, Opheim KE, Cox BM, Goldstein A. A peptide-like substance from pituitary that acts like morphine. I. Isolation. Life Sciences. 16: 1771-5. PMID 1171343 |
0.577 |
|
| 1975 |
Schulz R, Goldstein A. Irreversible alteration of opiate receptor function by a photoaffinity labelling reagent. Life Sciences. 16: 1843-1848. PMID 1152614 DOI: 10.1016/0024-3205(75)90288-X |
0.335 |
|
| 1975 |
Cox BM, Opheim KE, Teschemacher H, Goldstein A. A peptide-like substance from pituitary that acts like morphine. 2. Purification and properties. Life Sciences. 16: 1777-82. PMID 1152601 DOI: 10.1016/0024-3205(75)90272-6 |
0.658 |
|
| 1975 |
Dingledine R, Goldstein A. Single neuron studies of opiate action in the guinea pig myenteric plexus. Life Sciences. 17: 57-62. PMID 1143011 DOI: 10.1016/0024-3205(75)90235-0 |
0.487 |
|
| 1974 |
Dingledine R, Goldstein A, Kendig J. Effects of narcotic opiates and serotonin on the electrical behavior of neurons in the guinea pig myenteric plexus. Life Sciences. 14: 2299-309. PMID 4847817 DOI: 10.1016/0024-3205(74)90111-8 |
0.557 |
|
| 1974 |
Lowney LI, Schulz K, Lowery PJ, Goldstein A. Partial Purification of an Opiate Receptor from Mouse Brain Science. 183: 749-753. PMID 4821242 DOI: 10.1126/Science.183.4126.749 |
0.323 |
|
| 1974 |
Schulz R, Cartwright C, Goldstein A. Reversibility of morphine tolerance and dependence in guinea pig brain and myenteric plexus. Nature. 251: 329-331. PMID 4473718 DOI: 10.1038/251329A0 |
0.359 |
|
| 1973 |
Dingledine R, Goldstein A. Lethality of the morphinan isomers levorphanol and dextrorphan. British Journal of Pharmacology. 48: 718-20. PMID 4788214 DOI: 10.1111/j.1476-5381.1973.tb08261.x |
0.517 |
|
| 1973 |
Goldstein A, Judson BA, Sheehan P. Cellular and metabolic tolerance to an opioid narcotic in mouse brain British Journal of Pharmacology. 47: 138-140. PMID 4717014 DOI: 10.1111/J.1476-5381.1973.Tb08167.X |
0.325 |
|
| 1971 |
Goldstein A, Lowney LI, Pal BK. Stereospecific and nonspecific interactions of the morphine congener levorphanol in subcellular fractions of mouse brain. Proceedings of the National Academy of Sciences of the United States of America. 68: 1742-7. PMID 5288759 DOI: 10.1073/pnas.68.8.1742 |
0.325 |
|
| 1971 |
Hahn DL, Goldstein A. Amounts And Turnover Rates Of Brain Proteins In Morphine-Tolerant Mice Journal of Neurochemistry. 18: 1887-1893. PMID 5165755 DOI: 10.1111/J.1471-4159.1971.Tb09594.X |
0.318 |
|
| 1971 |
Cheney DL, Goldstein A. Tolerance to opioid narcotics: time course and reversibility of physical dependence in mice. Nature. 232: 477-8. PMID 4937208 DOI: 10.1038/232477a0 |
0.349 |
|
| 1970 |
Richter JA, Goldstein A. Tolerance to Opioid Narcotics, II. Cellular Tolerance to Levorphanol in Mouse Brain Proceedings of the National Academy of Sciences of the United States of America. 66: 944-951. PMID 5269255 DOI: 10.1073/Pnas.66.3.944 |
0.367 |
|
| 1969 |
Sharkawi M, Goldstein A. Antagonism by physostigmine of the “running fit” caused by levorphanol, a morphine congener, in mice British Journal of Pharmacology. 37: 123-128. PMID 5824928 DOI: 10.1111/J.1476-5381.1969.Tb09529.X |
0.34 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 1973 |
Goldstein A, Schulz R. Morphine‐tolerant longitudinal muscle strip from guinea‐pig ileum British Journal of Pharmacology. 48: 655-666. PMID 4799172 DOI: 10.1111/J.1476-5381.1973.Tb08254.X |
0.3 |
|
| 1984 |
Devi L, Goldstein A. Dynorphin converting enzyme with unusual specificity from rat brain Proceedings of the National Academy of Sciences of the United States of America. 81: 1892-1896. PMID 6143321 DOI: 10.1073/Pnas.81.6.1892 |
0.296 |
|
| 1975 |
Goldstein A, Hilgard ER. Failure of the opiate antagonist naloxone to modify hypnotic analgesia. Proceedings of the National Academy of Sciences of the United States of America. 72: 2041-3. PMID 1056010 |
0.296 |
|
| 1989 |
Goldstein A, Brutlag DL. Is there a relationship between DNA sequences encoding peptide ligands and their receptors? Proceedings of the National Academy of Sciences of the United States of America. 86: 42-5. PMID 2536158 DOI: 10.1073/Pnas.86.1.42 |
0.291 |
|
| 1983 |
Spampinato S, Goldstein A. Immunoreactive dynorphin in rat tissues and plasma Neuropeptides. 3: 193-212. DOI: 10.1016/0143-4179(83)90016-1 |
0.29 |
|
| 1983 |
Grevert P, Albert LH, Goldstein A. Partial antagonism of placebo analgesia by naloxone Pain. 16: 129-143. PMID 6308540 DOI: 10.1016/0304-3959(83)90203-8 |
0.29 |
|
| 1977 |
Grevert P, Goldstein A. Some effects of naloxone on behavior in the mouse. Psychopharmacology. 53: 111-113. PMID 408836 DOI: 10.1007/Bf00426478 |
0.29 |
|
| 1980 |
Romano C, Goldstein A. Stereospecific nicotine receptors on rat brain membranes Science. 210: 647-650. PMID 7433991 DOI: 10.1126/Science.7433991 |
0.29 |
|
| 1982 |
Fischli W, Goldstein A, Hunkapiller MW, Hood LE. Isolation and amino acid sequence analysis of a 4,000-dalton dynorphin from porcine pituitary Proceedings of the National Academy of Sciences of the United States of America. 79: 5435-5437. PMID 6127674 DOI: 10.1073/Pnas.79.17.5435 |
0.287 |
|
| 1971 |
Goldstein A, Judson BA. Alcohol dependence and opiate dependence: lack of relationship in mice. Science. 172: 290-292. PMID 5102945 DOI: 10.1126/Science.172.3980.290 |
0.284 |
|
| 2005 |
Rodd ZA, Bell RL, Zhang Y, Murphy JM, Goldstein A, Zaffaroni A, Li TK, McBride WJ. Regional heterogeneity for the intracranial self-administration of ethanol and acetaldehyde within the ventral tegmental area of alcohol-preferring (P) rats: involvement of dopamine and serotonin. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 30: 330-8. PMID 15383830 DOI: 10.1038/Sj.Npp.1300561 |
0.283 |
|
| 1977 |
Goldstein A, Hansteen RW. Evidence against involvement of endorphins in sexual arousal and orgasm in man. Archives of General Psychiatry. 34: 1179-1180. PMID 199128 DOI: 10.1001/Archpsyc.1977.01770220061006 |
0.281 |
|
| 1987 |
Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: Focus on opioid receptors Trends in Pharmacological Sciences. 8: 456-459. DOI: 10.1016/0165-6147(87)90038-1 |
0.281 |
|
| 1971 |
Goldstein A, Sheehan P, Goldstein J. Unsuccessful attempts to transfer morphine tolerance and passive avoidance by brain extracts. Nature. 233: 126-129. PMID 12058754 DOI: 10.1038/233126A0 |
0.279 |
|
| 1982 |
Goldstein A. "Immunoreactive dynorphin" in escherichia coli: Tracer degradation by a heat-stable endopeptidase Life Sciences. 31: 2267-2270. PMID 6131358 DOI: 10.1016/0024-3205(82)90134-5 |
0.279 |
|
| 2002 |
Rodd-Henricks ZA, Melendez RI, Zaffaroni A, Goldstein A, McBride WJ, Li TK. The reinforcing effects of acetaldehyde in the posterior ventral tegmental area of alcohol-preferring rats. Pharmacology, Biochemistry, and Behavior. 72: 55-64. PMID 11900769 DOI: 10.1016/S0091-3057(01)00733-X |
0.276 |
|
| 1972 |
Goldstein A. Heroin Addiction and the Role of Methadone in Its Treatment Archives of General Psychiatry. 26: 291-297. PMID 4622401 DOI: 10.1001/archpsyc.1972.01750220001001 |
0.275 |
|
| 1981 |
Judson BA, Carney TM, Goldstein A. Naltrexone treatment of heroin addiction: efficacy and safety in a double-blind dosage comparison. Drug and Alcohol Dependence. 7: 325-46. PMID 7023894 DOI: 10.1016/0376-8716(81)90049-1 |
0.269 |
|
| 1978 |
Grevert P, Baizman ER, Goldstein A. Naloxone effects on a nociceptive response of hypophysectomized and adrenalectomized mice. Life Sciences. 23: 723-728. PMID 692290 DOI: 10.1016/0024-3205(78)90072-3 |
0.269 |
|
| 1980 |
Goldstein A. Thrills in response to music and other stimuli Physiological Psychology. 8: 126-129. DOI: 10.3758/BF03326460 |
0.268 |
|
| 1973 |
Schulz R, Goldstein A. Morphine tolerance and supersensitivity to 5-hydroxytryptamine in the myenteric plexus of the guinea-pig. Nature. 244: 168-70. PMID 4355667 DOI: 10.1038/244168A0 |
0.267 |
|
| 1978 |
Trueblood B, Judson BA, Goldstein A. Acceptability of methadyl acetate (LAAM) as compared with methadone in a treatment program for heroin addicts. Drug and Alcohol Dependence. 3: 125-132. PMID 631012 DOI: 10.1016/0376-8716(78)90025-X |
0.265 |
|
| 1982 |
Judson BA, Goldstein A. Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers Drug and Alcohol Dependence. 10: 269-282. PMID 7166139 DOI: 10.1016/0376-8716(82)90021-7 |
0.265 |
|
| 2003 |
Rodd ZA, Bell RL, Zhang Y, Goldstein A, Zaffaroni A, McBride WJ, Li TK. Salsolinol produces reinforcing effects in the nucleus accumbens shell of alcohol-preferring (P) rats. Alcoholism, Clinical and Experimental Research. 27: 440-9. PMID 12658109 DOI: 10.1097/01.Alc.0000056612.89957.B4 |
0.264 |
|
| 1981 |
Romano C, Goldstein A, Jewell NP. Characterization of the receptor mediating the nicotine discriminative stimulus Psychopharmacology. 74: 310-315. PMID 6794072 DOI: 10.1007/BF00432737 |
0.255 |
|
| 1986 |
Devi L, Goldstein A. Conversion of leumorphin (dynorphin B-29) to dynorphin B and dynorphin B-14 by thiol protease activity Journal of Neurochemistry. 47: 154-157. PMID 2872272 DOI: 10.1111/J.1471-4159.1986.Tb02843.X |
0.255 |
|
| 1995 |
Goldstein A, Herrera J. Heroin addicts and methadone treatment in Albuquerque: a 22-year follow-up Drug and Alcohol Dependence. 40: 139-150. PMID 8745136 DOI: 10.1016/0376-8716(95)01205-2 |
0.254 |
|
| 1984 |
Judson BA, Goldstein A. Naltrexone treatment of heroin addiction: One-year follow-up Drug and Alcohol Dependence. 13: 357-365. PMID 6479015 DOI: 10.1016/0376-8716(84)90003-6 |
0.253 |
|
| 1975 |
Goldstein A, Hansteen RW, Horns WH. Control of methadone dosage by patients. Jama. 234: 734-737. DOI: 10.1001/Jama.1975.03260200050018 |
0.252 |
|
| 1980 |
Judson BA, Ortiz S, Crouse L, Carney TM, Goldstein A. A follow-up study of heroin addicts five years after first admission to a methadone treatment program. Drug and Alcohol Dependence. 6: 295-313. PMID 7460762 DOI: 10.1016/0376-8716(80)90197-0 |
0.246 |
|
| 1981 |
Watson SJ, Akil H, Ghazarossian VE, Goldstein A. Dynorphin immunocytochemical localization in brain and peripheral nervous system: Preliminary studies Proceedings of the National Academy of Sciences of the United States of America. 78: 1260-1263. PMID 6112743 DOI: 10.1073/PNAS.78.2.1260 |
0.244 |
|
| 1970 |
Richter JA, Goldstein A. The effects of morphine-like compounds on the light responses of the brine shrimp Artemia salina. Psychopharmacology. 17: 327-337. PMID 5523367 DOI: 10.1007/Bf00404238 |
0.244 |
|
| 2005 |
Quertemont E, Grant KA, Correa M, Arizzi MN, Salamone JD, Tambour S, Aragon CM, McBride WJ, Rodd ZA, Goldstein A, Zaffaroni A, Li TK, Pisano M, Diana M. The role of acetaldehyde in the central effects of ethanol. Alcoholism, Clinical and Experimental Research. 29: 221-34. PMID 15714045 DOI: 10.1097/01.Alc.0000156185.39073.D2 |
0.243 |
|
| 1960 |
Goldstein DB, Brown BJ, Goldstein A. Amino acid starvation in an Escherichia coli auxotroph II. Acid-soluble purine and pyrimidine derivatives in normal and starved cells Biochimica Et Biophysica Acta. 43: 55-61. PMID 13706632 DOI: 10.1016/0006-3002(60)90406-6 |
0.241 |
|
| 1982 |
Judson BA, Goldstein A. Prediction of long-term outcome for heroin addicts admitted to a methadone maintenance program Drug and Alcohol Dependence. 10: 383-391. PMID 7166147 DOI: 10.1016/0376-8716(82)90040-0 |
0.24 |
|
| 1982 |
Watson SJ, Akil H, Fischli W, Goldstein A, Zimmerman E, Nilaver G, Van Wimersma Greidanus TB. Dynorphin and vasopressin: Common localization in magnocellular neurons Science. 216: 85-87. PMID 6121376 DOI: 10.1126/SCIENCE.6121376 |
0.24 |
|
| 1985 |
Devi L, Goldstein A. Neuropeptide processing by single-step cleavage: Conversion of leumorphin (dynorphin B-29) to dynorphin B Biochemical and Biophysical Research Communications. 130: 1168-1176. PMID 2862869 DOI: 10.1016/0006-291X(85)91738-3 |
0.238 |
|
| 1972 |
Goldstein A. Blind comparison of once-daily and twice-daily dosage schedules in a methadone program Clinical Pharmacology and Therapeutics. 13: 59-63. PMID 4550323 DOI: 10.1002/Cpt197213159 |
0.238 |
|
| 1975 |
Horns WH, Rado M, Goldstein A. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride Clinical Pharmacology & Therapeutics. 17: 636-649. PMID 1139855 DOI: 10.1002/Cpt1975176636 |
0.237 |
|
| 2003 |
Goldstein A, Brown BW. Urine testing in methadone maintenance treatment: applications and limitations. Journal of Substance Abuse Treatment. 25: 61-3. PMID 14629984 DOI: 10.1016/S0740-5472(03)00066-7 |
0.236 |
|
| 1972 |
Leute RK, Ullman EF, Goldstein A, Herzenberg LA. Spin immunoassay technique for determination of morphine. Nature: New Biology. 236: 93-4. PMID 4336467 DOI: 10.1038/Newbio236093A0 |
0.236 |
|
| 1979 |
Judson BA, Goldstein A. Levo-alpha-acetylmethadol (LAAM) in the treatment of heroin addicts I. Dosage schedule for induction and stabilization Drug and Alcohol Dependence. 4: 461-466. PMID 533680 DOI: 10.1016/0376-8716(79)90024-3 |
0.236 |
|
| 1983 |
Judson BA, Goldstein A, Inturrisi CE. Methadyl Acetate (LAAM) in the Treatment of Heroin Addicts: II. Double-blind Comparison of Gradual and Abrupt Detoxification Archives of General Psychiatry. 40: 834-840. PMID 6347117 DOI: 10.1001/Archpsyc.1983.01790070024003 |
0.235 |
|
| 1982 |
Judson BA, Ortiz S, Crouse L, Carney TM, Goldstein A. A follow-up study of heroin addicts five years after first admission to a methadone treatment program International Journal of Rehabilitation Research. 5: 254-256. DOI: 10.1097/00004356-198206000-00023 |
0.235 |
|
| 1976 |
Goldstein A. Heroin Addiction: Sequential Treatment Employing Pharmacologic Supports Archives of General Psychiatry. 33: 353-358. PMID 1259524 DOI: 10.1001/archpsyc.1976.01770030061009 |
0.234 |
|
| 1979 |
Judson Ba, Himmelberger Du, Goldstein A. Measurement of urine temperature as an alternative to observed urination in a narcotic treatment program. American Journal of Drug and Alcohol Abuse. 6: 197-205. PMID 517492 DOI: 10.3109/00952997909007045 |
0.233 |
|
| 1979 |
Ross M, Berger PA, Goldstein A. Plasma β-endorphin immunoreactivity in schizophrenia Science. 205: 1163-1164. PMID 472735 DOI: 10.1126/Science.472735 |
0.232 |
|
| 1962 |
Carey NH, Goldstein A. Amino acid starvation in an Escherichia coli auxotroph IV. The incorporation of [14C]leucine into cell fractions and its transfer between them Biochimica Et Biophysica Acta. 55: 346-352. DOI: 10.1016/0926-6550(62)90266-9 |
0.23 |
|
| 1977 |
Goldstein A, Horns WH, Hansteen RW. Is on-site urine testing of therapeutic value in a methadone treatment program? Substance Use & Misuse. 12: 717-728. PMID 591135 DOI: 10.3109/10826087709024121 |
0.228 |
|
| 1970 |
Goldstein A, Brown BW. Urine Testing Schedules in Methadone Maintenance Treatment of Heroin Addiction Jama. 214: 311-315. DOI: 10.1001/Jama.1970.03180020031006 |
0.227 |
|
| 2004 |
McBride WJ, Rodd ZA, Goldstein A, Zaffaroni A, Li T-. CONTRASTING THE REINFORCING ACTIONS OF ACETALDEHYDE AND ETHANOL WITHIN THE VENTRAL TEGMENTAL AREA OF ALCOHOL-PREFERRING (P) RATS. Alcoholism: Clinical & Experimental Research. 28: 82A. DOI: 10.1097/00000374-200408002-00455 |
0.226 |
|
| 1964 |
Goldstein A, Goldstein DB, Lowney LI. Protein synthesis at 0°C in Escherichia coli Journal of Molecular Biology. 9: 213-235. PMID 14200385 DOI: 10.1016/S0022-2836(64)80102-9 |
0.226 |
|
| 1953 |
Goldstein DB, Goldstein A. An adaptive bacterial cholinesterase from a Pseudomonas species. Microbiology. 8: 8-17. PMID 13035026 DOI: 10.1099/00221287-8-1-8 |
0.225 |
|
| 1967 |
Das HK, Goldstein A, Lowney LI. Attachment of ribosomes to nascent messenger RNA in Escherichia coli. Journal of Molecular Biology. 24: 231-245. PMID 5339872 DOI: 10.1016/0022-2836(67)90329-4 |
0.224 |
|
| 1959 |
Goldstein A, Goldstein DB, Brown BJ, Chou S. Amino acid starvation in an Escherichia coli auxotroph. I. Effects on protein and nucleic acid synthesis and on cell devision. Biochimica Et Biophysica Acta. 36: 163-172. PMID 13850757 DOI: 10.1016/0006-3002(59)90080-0 |
0.223 |
|
| 1983 |
Judson BA, Goldstein A. Episodes of heroin use during maintenance treatment with stable dosage of (-)-α-acetylmethadol (methadyl acetate, LAAM) Drug and Alcohol Dependence. 11: 271-278. PMID 6617466 DOI: 10.1016/0376-8716(83)90018-2 |
0.223 |
|
| 1968 |
Das HK, Goldstein A. Limited capacity for protein synthesis at zero degrees centigrade in Escherichia coli Journal of Molecular Biology. 31: 209-226. PMID 4865483 DOI: 10.1016/0022-2836(68)90440-3 |
0.223 |
|
| 1987 |
Goldstein A. Criteria of a Pharmacologic Withdrawal Syndrome Archives of General Psychiatry. 44: 392. PMID 3566460 DOI: 10.1001/archpsyc.1987.01800160108016 |
0.222 |
|
| 1959 |
Goldstein A, Brown BJ. Amino acid starvation in an Escherichia coli auxotroph. III. Incorporation of 32P into ribonucleic acid and other cell components. Biochimica Et Biophysica Acta. 44: 491-500. PMID 13706624 DOI: 10.1016/0006-3002(60)91603-6 |
0.222 |
|
| 1999 |
Naranda T, Wong K, Kaufman RI, Goldstein A, Olsson L. Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site Proceedings of the National Academy of Sciences of the United States of America. 96: 7569-7574. PMID 10377456 DOI: 10.1073/pnas.96.13.7569 |
0.221 |
|
| 1977 |
Grevert P, Masover B, Goldstein A. Failure of Methadone and Levomethadyl Acetate (Levo-Alpha-Acetylmethadol, LAAM) Maintenance to Affect Memory Archives of General Psychiatry. 34: 849-853. PMID 879977 DOI: 10.1001/Archpsyc.1977.01770190111011 |
0.22 |
|
| 1961 |
Goldstein A, Brown BJ. Effect of sonic oscillation upon “old” and “new” nucleic acids in Escherichia coli Biochimica Et Biophysica Acta. 53: 19-28. PMID 13899871 DOI: 10.1016/0006-3002(61)90790-9 |
0.219 |
|
| 1983 |
Cone RI, Weber E, Barchas JD, Goldstein A. Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 3: 2146-52. PMID 6138396 DOI: 10.1523/Jneurosci.03-11-02146.1983 |
0.218 |
|
| 1971 |
Goldstein A. Blind dosage comparisons and other studies in a large methadone program Journal of Psychoactive Drugs. 4: 177-181. DOI: 10.1080/02791072.1971.10471806 |
0.216 |
|
| 1964 |
Goldstein A. Wakefulness caused by caffeine Naunyn-Schmiedebergs Archiv FüR Experimentelle Pathologie Und Pharmakologie. 248: 269-278. PMID 14230240 DOI: 10.1007/BF00348597 |
0.215 |
|
| 1980 |
GOLDSTEIN A. ChemInform Abstract: OBSCURE BRAIN PEPTIDE IS POTENT PAINKILLER Chemischer Informationsdienst. 11. DOI: 10.1002/chin.198017293 |
0.215 |
|
| 1961 |
Goldstein A, Brown BJ. Addition of amino acid to C-terminal ends of growing protein chains in Escherichia coli. Biochimica Et Biophysica Acta. 53: 438-439. PMID 13899870 DOI: 10.1016/0006-3002(61)90467-X |
0.214 |
|
| 1997 |
Goldstein A, Wallace ME. Caffeine dependence in schoolchildren Experimental and Clinical Psychopharmacology. 5: 388-392. PMID 9386965 DOI: 10.1037//1064-1297.5.4.388 |
0.213 |
|
| 1952 |
Goldstein A. Effect of penicillin on streptomycin-dependent variants in Escherichia coli populations Science. 116: 113. PMID 14950199 DOI: 10.1126/Science.116.3005.113 |
0.213 |
|
| 1969 |
Goldstein A, Kaizer S, Whitby O. Psychotropic effects of caffeine in man. IV. Quantitative and qualitative differences associated with habituation to coffee. Clinical Pharmacology & Therapeutics. 10: 489-497. PMID 5793753 DOI: 10.1002/Cpt1969104489 |
0.212 |
|
| 1962 |
Goldstein A, Warren R. Passage of caffeine into human gonadal and fetal tissue. Biochemical Pharmacology. 11: 166-168. PMID 13899873 DOI: 10.1016/0006-2952(62)90106-5 |
0.212 |
|
| 1972 |
Leute R, Ullman EF, Goldstein A. Spin immunoassay of opiate narcotics in urine and saliva. Jama. 221: 1231-1234. DOI: 10.1001/Jama.1972.03200240013004 |
0.211 |
|
| 1976 |
Lombardo WK, Lombardo B, Goldstein A. Cognitive Functioning under Moderate and Low Dosage Methadone Maintenance Substance Use & Misuse. 11: 389-401. PMID 965122 DOI: 10.3109/10826087609056158 |
0.211 |
|
| 1982 |
Sweetnam PM, Neale JH, Barker JL, Goldstein A. Localization of immunoreactive dynorphin in neurons cultured from spinal cord and dorsal root ganglia. Proceedings of the National Academy of Sciences of the United States of America. 79: 6742-6. PMID 6128736 |
0.204 |
|
| 1978 |
Goldstein A. Endorphins: physiology and clinical implications Annals of the New York Academy of Sciences. 311: 49-58. PMID 217294 DOI: 10.1002/j.2326-1951.1978.tb01642.x |
0.203 |
|
| 1973 |
Goldstein A. Comments on the "isolation, identification and synthesis of a specific-behaviour-inducing brain peptide" Nature. 242: 60-62. PMID 4735102 DOI: 10.1038/242060a0 |
0.2 |
|
| 1965 |
Goldstein A, Kirschbaum JB, Roman A. Direction of synthesis of messenger RNA in cells of Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America. 54: 1669-1675. PMID 5326384 DOI: 10.1073/Pnas.54.6.1669 |
0.198 |
|
| 1990 |
Goldstein A, Kalant H. Drug policy: striking the right balance. Science (New York, N.Y.). 249: 1513-21. PMID 2218493 DOI: 10.1126/Science.2218493 |
0.194 |
|
| 1962 |
GOLDSTEIN A. Chain growth of proteins: some consequences for the coding problem Journal of Molecular Biology. 4: 121-122. PMID 13899874 DOI: 10.1016/S0022-2836(62)80045-X |
0.189 |
|
| 1949 |
Goldstein A. A "Free Manometer" Method of Using the Standard Warburg Apparatus Science (New York, N.Y.). 110: 400. PMID 17844562 DOI: 10.1126/Science.110.2859.400 |
0.189 |
|
| 1969 |
Goldstein A, Kaizer S. Psychotropic effects of caffeine in man. III. A questionnaire survey of coffee drinking and its effects in a group of housewives Clinical Pharmacology & Therapeutics. 10: 477-488. PMID 5793752 DOI: 10.1002/Cpt1969104477 |
0.189 |
|
| 1988 |
Goldstein A. Collaboration and responsibility Science. 242: 1623-1623. DOI: 10.1126/Science.3201249 |
0.179 |
|
| 1962 |
Goldstein A, Warren R. Lack of relationship between gastric carcinoma and intake of beverages containing caffeine. Cancer. 15: 1261-1263. PMID 13948794 DOI: 10.1002/1097-0142(196211/12)15:6<1261::Aid-Cncr2820150622>3.0.Co;2-X |
0.173 |
|
| 1997 |
Goldstein A. A rewarding research pathway Annual Review of Pharmacology and Toxicology. 37: 1-28. PMID 9131244 DOI: 10.1146/Annurev.Pharmtox.37.1.1 |
0.169 |
|
| 1989 |
Goldstein A. "Soul-Searching" and China Science. 245: 1165-1165. DOI: 10.1126/Science.245.4923.1165-A |
0.167 |
|
| 1991 |
Stagsted J, Baase W, Goldstein A, Olsson L. A preformed, ordered structure of a 25-residue peptide derived from a major histocompatibility complex class I antigen is required to affect insulin receptor function Journal of Biological Chemistry. 266: 12844-12847. DOI: 10.1016/s0021-9258(18)98770-3 |
0.164 |
|
| 2002 |
Naranda T, Kaufman RI, Li J, Wong K, Boge A, Halle N D, Fung KY, Duncan MW, Andersen N, Goldstein A, Olsson L. Activation of Erythropoietin Receptor through a Novel Extracellular Binding Site. Endocrinology. 143: 2293-2302. PMID 28204443 DOI: 10.1210/endo.143.6.8860 |
0.126 |
|
| 1971 |
Cheney DL, Goldstein A, Algeri S, Costa E. Narcotic tolerance and dependence: lack of relationship with serotonin turnover in the brain. Science (New York, N.Y.). 171: 1169-70. PMID 5544876 |
0.124 |
|
| 1986 |
Goldstein A. The Sidney Cohen lectureship in drug abuse medicine Journal of Substance Abuse Treatment. 3: 157-161. PMID 3806728 DOI: 10.1016/0740-5472(86)90016-4 |
0.123 |
|
| 1983 |
Spampinato S, Ferri S, Goldstein A. Dynorphin immunoreactivity in rat gastrointestinal tract Regulatory Peptides. 5: 43-44. DOI: 10.1016/0167-0115(83)90685-7 |
0.12 |
|
| 1987 |
Xie G, Goldstein A. Characterization of big dynorphins from rat brain and spinal cord The Journal of Neuroscience. 7: 2049-2055. DOI: 10.1523/JNEUROSCI.07-07-02049.1987 |
0.105 |
|
| 1978 |
Grevert P, Goldstein A. Endorphins: naloxone fails to alter experimental pain or mood in humans. Science (New York, N.Y.). 199: 1093-5. PMID 343250 DOI: 10.1126/SCIENCE.343250 |
0.09 |
|
| 1951 |
Goldstein A. Properties and behavior of purified human plasma cholinesterase. III. Competitive inhibition by prostigmine and other alkaloids with special reference to differences in kinetic behavior Archives of Biochemistry and Biophysics. 34: 169-188. PMID 14904048 DOI: 10.1016/S0003-9861(51)80023-7 |
0.078 |
|
| 1951 |
GOLDSTEIN A, DOHERTY ME. Properties and behavior of purified human plasma cholinesterase. II. Inactivation by mercuric chloride. Archives of Biochemistry and Biophysics. 33: 35-49. PMID 14857773 DOI: 10.1016/0003-9861(51)90080-X |
0.06 |
|
| 2004 |
GOLDSTEIN A, HAMLISCH RE. Properties and behavior of purified human plasma cholinesterase. IV. Enzymatic destruction of the inhibitors prostigmine and physostigmine. Archives of Biochemistry and Biophysics. 35: 12-22. PMID 14915538 DOI: 10.1016/S0003-9861(52)80048-7 |
0.06 |
|
| 1970 |
Goldstein A, Aronow L, Kalman SM. Principles of Drug Action. The Basis of Pharmacology Journal of Medicinal Chemistry. 13: 337-337. DOI: 10.1021/JM00296A900 |
0.059 |
|
| 1975 |
Goldstein A. On the role off chemotherapy in the treatment of heroin addiction American Journal of Drug and Alcohol Abuse. 2: 279-288. PMID 1227291 DOI: 10.3109/00952997509005653 |
0.052 |
|
| 1973 |
Goldstein A. Molecular Aspects of Narcotic Addiction. Annals of Internal Medicine. 78: 813. DOI: 10.7326/0003-4819-78-5-813_7 |
0.05 |
|
| 1951 |
GOLDSTEIN A, DOHERTY ME. Properties and behavior of purified human plasma cholinesterase. I. Stability and thermal denaturation. Archives of Biochemistry and Biophysics. 33: 22-34. PMID 14857772 DOI: 10.1016/0003-9861(51)90079-3 |
0.046 |
|
| Hide low-probability matches. |